A portable handheld molecular diagnostic device designed for on-the-go pathogen detection. This instrument simplifies sample handling and improves diagnostic efficiency in point-of-care settings.
Manufactured by
Nanjing, Jiangsu, China
Jiangsu Medomics Medical Technology Co., Ltd., founded in October 2017, is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments. Medomics owns two R D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 2,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions. At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshang. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease (National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health). The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2. At present, Medomics s series products of SARS-Cov-2 detection have been developed according to ISO 13485 Quality System and European CE Certification.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Genes 2Me Private Ltd
India · 1 relevant product
AmplexDiagnostics GmbH
Germany · 1 relevant product
Guangdong Ascendas Genomics Technology Co., Ltd.
China · 1 relevant product
Molbio Diagnostics Limited
India · 1 relevant product
TMD LAB CO., LTD.
South Korea · 1 relevant product
Vircell S.L.
Spain · 2 relevant products
Anbio Biotechnology Limited
Germany · 1 relevant product
Axxin
Australia · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 1 relevant product
Shenzhen Diasia Biomedical Technology Co.,Ltd
China · 1 relevant product
14 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 27 closest product alternatives
Genes 2Me Private Ltd · India
Compact point-of-care device for on-site molecular testing without requiring centralized laboratory infrastructure. Enables rapid diagnostic decision-making.
AmplexDiagnostics GmbH · Germany
A lightweight and robust diagnostic unit designed for rapid individual molecular testing 24/7. The device features two independent heating blocks for maximum flexibility, intuitive software, and an integrated barcode scanner. It is a modern, compact unit that meets all requirements for contemporary molecular diagnostic laboratories.
Guangdong Ascendas Genomics Technology Co., Ltd. · China
Portable microfluidic-based nucleic acid testing device for rapid point-of-care molecular diagnostics. Enables on-site testing with minimal sample preparation and reduced turnaround time.
Molbio Diagnostics Limited · India
A compact diagnostic device designed for mobility and deployment in remote healthcare settings. Delivers laboratory-grade diagnostic capabilities in an ultraportable format for point-of-need testing.
TMD LAB CO., LTD. · South Korea
Portable point-of-care testing device for immediate clinical results. Suitable for emergency departments and remote clinical settings.
Vircell S.L. · Spain
A compact molecular biology instrument for real-time PCR applications. This system enables smaller laboratories to perform molecular diagnostics with simplified workflows.
Anbio Biotechnology Limited · Germany
Portable point-of-care testing instrument for bedside biomarker analysis. Supports rapid clinical decision-making in acute care settings.
Axxin · Australia
Portable diagnostic instrument with compact design suitable for any clinical or field setting. Combines powerful diagnostic capability with ease of transportation and use.
ZIODIA Co., Ltd. · South Korea
Portable diagnostic device enabling rapid testing at the point of care using lab-on-a-chip technology. Reduces turnaround time and provides clinical-grade results in a compact, user-friendly format.
Shenzhen Diasia Biomedical Technology Co.,Ltd · China
A miniaturized real-time quantitative PCR system for molecular diagnostics. It performs nucleic acid amplification and detection for molecular pathogen identification and genetic testing in point-of-care and laboratory environments.
Bioperfectus · China
Point-of-care testing platform for rapid diagnostic results at bedside or decentralized locations. Supports multiple assay types for infectious disease detection.
Genomtec S.A. · Poland
A mobile point-of-care testing (PoCT) platform for genetic diagnostics designed for use in medical offices, clinics, hospitals, and pharmacies. The system enables rapid genetic diagnostics at the patient care location using SNAAT technology without requiring complex laboratory procedures.
15 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products